Foundry Partners, LLC Amgen Inc Transaction History

Foundry Partners, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 23, 2020	SELL	$234.65 - $260.95 $15.3 Million - $17 Million	-65,248 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $2.2 Million - $2.69 Million	11,099 Added 20.5%	65,248 $15.4 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $41,004 - $54,382	225 Added 0.42%	54,149 $11 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $3.11 Million - $4 Million	-16,461 Reduced 23.39%	53,924 $13 Million
Q3 2019 Oct 23, 2019	SELL	$174.11 - $208.62 $4.77 Million - $5.72 Million	-27,420 Reduced 28.04%	70,385 $13.6 Million
Q2 2019 Jul 18, 2019	BUY	$166.7 - $195.41 $91,685 - $107,475	550 Added 0.57%	97,805 $18 Million
Q1 2019 Apr 22, 2019	BUY	$180.87 - $203.88 $628,523 - $708,483	3,475 Added 3.71%	97,255 $18.5 Million
Q4 2018 Jan 10, 2019	SELL	$178.4 - $208.25 $526,280 - $614,337	-2,950 Reduced 3.05%	93,780 $19.4 Million
Q4 2018 Jan 10, 2019	BUY	$178.4 - $208.25 $526,280 - $614,337	2,950 Added 3.15%	96,730 $18.8 Million
Q3 2018 Oct 17, 2018	BUY	$185.29 - $208.89 $894,024 - $1.01 Million	4,825 Added 5.42%	93,780 $19.4 Million
Q2 2018 Jul 19, 2018	SELL	$166.05 - $186.51 $4.46 Million - $5.01 Million	-26,865 Reduced 23.2%	88,955 $16.4 Million
Q1 2018 May 16, 2018	BUY	$169.43 - $198.0 $5.32 Million - $6.22 Million	31,390 Added 37.18%	115,820 $19.7 Million
Q4 2017 Jan 25, 2018	SELL	$168.79 - $188.59 $734,236 - $820,366	-4,350 Reduced 4.9%	84,430 $14.7 Million
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $14.9 Million - $17 Million	88,780	88,780 $16.6 Million

3,121

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.